1-Hydroxyyohimbine and Its Derivatives: New Potent A2-Blockers for the Treatment of Erectile Dysfunction

Heterocycles - Japan
doi 10.3987/com-06-s(o)26
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Institute of Heterocyclic Chemistry

Related search

Apomorphine SL (Uprima®): A New Treatment for the Management of Erectile Dysfunction

International Journal of Impotence Research
Urology
2001English

Treatment of Priapism Secondary to Drugs for Erectile Dysfunction

Advances in Urology
GynecologyUrologyObstetrics
2019English

Modulation of Soluble Guanylate Cyclase for the Treatment of Erectile Dysfunction

Physiology
Physiology
2013English

Modern Technologies for Monitoring the Effectiveness of Erectile Dysfunction Diagnosis and Treatment

Effective Pharmacotherapy
2019English

Chapter 7Oral Drug Treatment of Erectile Dysfunction

International Journal of Impotence Research
Urology
2003English

The Future Is Today: Emerging Drugs for the Treatment of Erectile Dysfunction

Expert Opinion on Emerging Drugs
Pharmacology
2010English

Treatment With Nano-Genistein for the Prevention of Radiation-Induced Erectile Dysfunction

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Trazodone, a Double Blind Trial for Treatment of Erectile Dysfunction

International Journal of Impotence Research
Urology
1997English

Prevalence of Erectile Dysfunction in HTLV-1–Infected Patients and Its Association With Overactive Bladder

Urology
Urology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy